International Patient Master Guide

Colorectal Cancer Treatment and Surgery for International Patients in India

The complete planning guide: colon versus rectum, staging, molecular testing, surgery, total neoadjuvant therapy, stoma, metastatic disease, travel, cost and follow-up

X-ray style illustration showing the colorectal cancer areaX-ray style medical illustration - colorectal cancerX-ray style illustration of a cancer cell
Stay in IndiaAbout 2-4 weeks
Complex surgery3-5 weeks or longer
Published byIndia Cancer Surgery Editorial TeamResearch & Editorial DevelopmentMedical Experts at India Cancer Surgery TeamMedically Reviewed and Updated

Colorectal cancer includes cancers arising in the colon and rectum, but the two should not be treated as one identical disease. Colon cancer is commonly managed with oncologic bowel resection followed by stage-directed systemic therapy. Rectal cancer requires precise pelvic MRI staging and may need chemotherapy and/or radiotherapy before surgery, particularly when the tumour threatens the mesorectal fascia, involves nodes or is locally advanced.

Modern treatment aims to cure localized disease while preserving bowel, urinary and sexual function whenever oncologically safe. High-quality surgery requires removal of the tumour with its vascular lymphatic drainage and adequate margins. In rectal cancer, total mesorectal excision quality is particularly important. Selected patients may avoid a permanent stoma, while others need temporary diversion or an abdominoperineal resection for safe cancer clearance.

International patients considering India should obtain a stage-specific treatment sequence before travel. The plan should address pathology, colonoscopy, CT staging, rectal MRI when relevant, mismatch-repair/MSI status, molecular testing in advanced disease, whether treatment should begin before surgery, the likelihood of a stoma, and whether liver, lung or peritoneal metastases are potentially treatable with curative intent.

A bowel cancer diagnosis, and the possibility of a stoma, can be frightening. This guide is written to help you understand the questions that matter, ask for a complete stage-specific plan and judge whether travelling for treatment makes sense for you. It does not promise outcomes; every cancer and every patient is different.

Short Answer: Is India a Good Option for Colorectal Cancer Treatment?

For many patients, it can be. India has experienced colorectal oncology teams offering laparoscopic and robotic surgery, sphincter-preserving rectal surgery, modern pelvic radiotherapy, systemic therapy and combined liver or peritoneal treatment, usually at a much lower private price than the USA, UK and Australia. But the first question is clinical: is the tumour in the colon or rectum, what is the exact stage, and should treatment begin with surgery or with chemotherapy and radiation? Rectal cancer patients should not book surgery before MRI-based sequencing is clear. Complete obstruction, perforation, uncontrolled bleeding, sepsis or severe dehydration needs urgent local treatment, not travel. Start with a remote review of your colonoscopy, pathology and scans, and compare the whole pathway, not the surgery price alone.

Quick Facts - Colorectal Cancer Treatment and Surgery for International Patients in India

TopicInternational-Patient Planning Point
Colon vs rectumTreatment sequence differs; rectal cancer often requires pelvic MRI and neoadjuvant planning
DiagnosisColonoscopy with biopsy is standard in most cases
StagingCT chest/abdomen/pelvis; high-resolution pelvic MRI for rectal cancer
BiomarkersMMR/MSI for all colorectal cancers; RAS/BRAF and other testing in advanced disease as indicated
Main operationsRight/left colectomy, sigmoid colectomy, anterior resection/TME, APR and selected local excision
Minimally invasive surgeryLaparoscopic or robotic approaches are suitable for many cases when oncologic principles can be maintained
StomaMay be temporary, permanent or unnecessary depending on tumour level, reconstruction and safety
Metastatic diseaseSelected liver/lung metastases can be resected/ablated; systemic therapy remains central
India stayOften about 2-4 weeks for uncomplicated surgery; longer after complex rectal/metastatic surgery
India surgery costBroadly US$5,000-12,000 for many major resections; complex multiorgan/metastatic procedures cost more
Records to sendColonoscopy and biopsy, pathology, CT, pelvic MRI for rectal cancer, CEA, MMR/MSI and molecular reports, and prior treatment records
Major Indian hubsDelhi NCR, Mumbai, Chennai, Bengaluru, Hyderabad and other tertiary colorectal oncology centres
CompanionStrongly advised throughout the stay and the journey home, especially with a stoma or after rectal surgery

Key principle: The most important question is not simply whether a tumour can be removed. It is whether the complete treatment sequence gives the best chance of cancer control while preserving function and avoiding unnecessary permanent stoma or treatment morbidity.

Part 1

Why India, Diagnosis and Staging

Why Do International Patients Choose India for Colorectal Cancer Treatment?

Patients travel for colorectal cancer care for practical reasons, and the strongest ones are about reaching an experienced multidisciplinary team at a price that does not force a compromise on the plan:

  • Lower cost. Private Indian hospitals often quote much less than self-pay prices in the USA, UK, Australia and other high-cost markets for surgery and radiation, although imported targeted drugs may show a much narrower gap.
  • Experienced colorectal teams. Major cancer centres have colorectal surgeons who perform laparoscopic, robotic and sphincter-preserving rectal surgery as part of a wider oncology service.
  • Comprehensive backup. Pelvic MRI, GI pathology, medical and radiation oncology, liver and thoracic surgery, interventional radiology, ICU and stoma nursing are often in the same hospital.
  • Modern pelvic radiotherapy and systemic therapy. Total neoadjuvant therapy and image-guided radiation can often be delivered within one pathway.
  • Multidisciplinary review. A tumour board can decide whether to operate first, treat first, or treat metastases with curative intent.
  • Timely access. Patients facing long waits or limited local options can often be assessed promptly once the records are reviewed, though a hurried decision on incomplete staging helps no one.
  • International patient support and English-speaking teams. Major hospitals typically help with appointments, hospital letters for visas, airport pick-up and accommodation guidance.
  • A plan you can review first. A remote review can state the stage and proposed sequence before you commit to travel, and may show that treatment close to home is the better choice.

Emergencies Are Different

Complete bowel obstruction, perforation, peritonitis, uncontrolled bleeding, sepsis or severe dehydration needs immediate local care. Do not delay emergency treatment to arrange international travel.

Patient Tip

Low cost should be the beginning of your evaluation, not the end of it. The sections that follow explain how to judge whether the proposed sequence is sensible, how to assess the team and how to compare the whole pathway rather than the surgery price alone.

How Does India Compare with Other Medical Travel Destinations?

Many patients also look at colorectal programmes abroad before deciding. There is no single best country for every patient; the right choice depends on where you live, your cancer and what you can verify about the surgeon and hospital. These are the factors worth comparing:

FactorWhat to compareHow India generally fares
CostThe full itemized pathway: surgery, stoma, radiation, drugs, ICU, tests and exclusionsOften much lower than self-pay pricing in Western countries for surgery and radiation; imported-drug savings vary
Surgeon and team experienceColorectal and rectal cancer volume, sphincter-preservation and leak rates, and a genuine tumour boardMajor Indian centres have experienced teams; always verify surgeon and centre volume
Imaging and pathologyDedicated pelvic MRI reading, MMR/MSI and molecular testingAvailable at large cancer centres; confirm the specific hospital
Radiation and systemic therapyPelvic radiotherapy technique, TNT protocols and access to targeted drugsOften available in the same hospital; confirm for your case
LanguageWhether doctors and nurses communicate easily with youEnglish is widely used by medical teams in major Indian hospitals
Distance and flight timeLength of the flight and the 2-5 weeks or more you may need to stayDepends on where you live: relatively close for patients from South Asia, the Middle East and East Africa, and a long-haul journey from the Americas and parts of Europe
VisaVisa type, processing time and attendant rulesIndia has a dedicated medical visa system with an attendant category; always confirm current rules for your nationality
Follow-upWho will give chemotherapy, colonoscopy and surveillance and manage a stoma at homeDepends on the team; ask for a defined hand-over plan before you commit

A Fair Way to Compare Destinations

  • Ask every destination for the same itemized written plan (operation, approach, stoma plan, radiation, drugs and exclusions).
  • Compare the clinical sequence first and the price second.
  • Compare the total trip cost - treatment, a contingency for complications, flights, accommodation for weeks, companion and local transport.
  • Judge the colorectal team and hospital, not just the country or a promise of robotic surgery.
  • Compare the follow-up plan: who will give continuing treatment, colonoscopy and surveillance at home?

Colon Cancer and Rectal Cancer Are Different for International Patients in India for Colorectal Cancer

The colon occupies most of the large bowel, while the rectum lies within the pelvis. Pelvic anatomy, circumferential margins and sphincter function make rectal cancer treatment more complex. Treatment recommendations should state the exact tumour location.

Symptoms and Warning Signs

Possible symptoms include rectal bleeding, change in bowel habit, iron-deficiency anaemia, unexplained weight loss, abdominal pain, obstruction or persistent tenesmus. Some cancers are found through screening before symptoms develop. Symptoms are not specific; diagnosis requires investigation.

Colonoscopy and Biopsy

Colonoscopy visualizes the colon, allows biopsy and can detect synchronous polyps or cancers. If an obstructing tumour prevents complete colonoscopy, the remaining colon should be evaluated later or by an appropriate alternative. Pathology should confirm malignancy before planned systemic therapy.

Pathology

Most colorectal cancers are adenocarcinomas. Pathology reports describe differentiation/grade and, after surgery, depth of invasion, lymph nodes, margins, lymphovascular/perineural invasion and other prognostic features. Rare histologies require individualized management.

Mismatch Repair and MSI

MMR protein testing or microsatellite-instability testing identifies deficient MMR/MSI-high tumours. Results can indicate Lynch syndrome risk, influence prognosis and strongly predict benefit from checkpoint immunotherapy in advanced disease. Abnormal results may prompt germline genetic evaluation.

Lynch Syndrome

Lynch syndrome is an inherited cancer-predisposition syndrome involving mismatch-repair genes. It can affect the extent of colon surgery and surveillance of the remaining bowel and other organs. Genetic counselling is important for patients and relatives.

Familial Adenomatous Polyposis

FAP causes numerous colorectal adenomas and very high lifetime cancer risk. Surgical strategy can involve removal of the colon and sometimes rectum, depending on polyp burden and cancer location. Management differs fundamentally from sporadic cancer.

CEA Tumour Marker

Carcinoembryonic antigen is useful as a baseline and for surveillance in many patients, but it is neither sensitive nor specific enough to diagnose colorectal cancer by itself. A normal CEA does not exclude recurrence.

CT Staging for International Patients in India for Colorectal Cancer

Contrast CT of chest, abdomen and pelvis evaluates regional and distant disease, particularly liver and lung metastases. Additional imaging is used when lesions require characterization. Imaging should be reviewed in a multidisciplinary context.

Pelvic MRI for Rectal Cancer

High-resolution MRI assesses tumour depth, mesorectal nodes, extramural vascular invasion, sphincter relationship and distance to the mesorectal fascia. These findings guide neoadjuvant treatment and surgical planning. A generic abdominal MRI is not a substitute for a rectal-cancer protocol.

Endorectal Ultrasound

Endorectal ultrasound can help stage selected early rectal tumours, particularly when local excision is being considered. MRI is generally more important for broader pelvic treatment planning. Its usefulness is operator- and tumour-dependent.

PET-CT

PET-CT is not routinely necessary for every newly diagnosed localized colorectal cancer. It can be useful selectively when conventional imaging is equivocal or potentially curative treatment of metastatic disease is being planned. Routine use can add cost without changing management.

Clinical Stage and TNM

TNM staging describes tumour penetration, regional nodes and distant metastases. Stage I-III disease is generally localized/regional; stage IV includes distant metastases, but selected stage IV disease can still be treated with curative intent. Stage alone does not define resectability.

Colon and Rectal Cancer at a Glance

FeatureColon cancerRectal cancer
LocationMost of the large bowelWithin the pelvis, close to the sphincter, bladder and sexual organs
Key staging toolsCT chest/abdomen/pelvis, CEA, MMR/MSIDedicated pelvic MRI, plus CT, CEA and MMR/MSI; sometimes endorectal ultrasound
Typical sequenceSurgery first for many; adjuvant chemotherapy by pathological stageOften chemotherapy and/or radiation before surgery when MRI shows risk
Surgery focusOncologic resection with its vascular lymphatic drainageTotal mesorectal excision, circumferential margin and sphincter planning
StomaLess often neededTemporary, permanent or none, depending on tumour level and safety

Making the Remote Review Count

  • Send the colonoscopy report and images, biopsy and pathology
  • Send CT chest/abdomen/pelvis and, for rectal cancer, the pelvic MRI, preferably as DICOM images rather than reports alone
  • Include CEA, MMR/MSI results and any RAS/BRAF or other molecular reports
  • Include prior chemotherapy, radiation and operative notes
  • Ask for the stage, the proposed sequence and the chance of a stoma before surgery is quoted

Send your colonoscopy and biopsy reports, pathology, CT chest/abdomen/pelvis, pelvic MRI for rectal cancer, CEA, MMR/MSI and any RAS/BRAF or molecular reports, plus prior chemotherapy, radiation and operative notes, with imaging in DICOM format where possible. You will receive a preliminary opinion covering whether the cancer is colon or rectal and its stage, whether treatment should begin with surgery or neoadjuvant therapy, the likelihood of sphincter preservation and a stoma, the stay in India, an itemized cost estimate and a follow-up plan, so you can decide with a clear picture in hand.

Part 2

Colon Cancer Surgery for International Patients in India for Colorectal Cancer

Right-Sided Colon Cancer

Right colectomy removes the tumour-bearing right colon with associated mesentery and lymphovascular pedicle. The small bowel is usually joined to the remaining colon. Extent varies with tumour location and vascular anatomy.

Left and Sigmoid Colon Cancer

Left or sigmoid colectomy removes the involved segment and regional lymphatic drainage, followed by bowel reconnection when safe. Obstruction or perforation can alter the operation. Adequate margins and mesocolic resection remain central.

Complete Mesocolic Excision

CME principles emphasize sharp dissection along embryological planes and central vascular lymphadenectomy. The exact extent should be balanced against anatomy and complication risk. The quality of oncologic surgery matters more than a label.

Laparoscopic Colon Cancer Surgery

Laparoscopic colectomy can provide equivalent oncologic resection in suitable patients with smaller incisions and faster early recovery. Very bulky, invasive or emergency tumours may require open surgery. Surgeon experience is important.

Robotic Colon Cancer Surgery for International Patients in India for Colorectal Cancer

Robotic systems can facilitate intracorporeal dissection and suturing, but many colon resections are also efficiently performed laparoscopically. The robot should add technical value rather than simply cost. Cancer outcomes depend on resection quality.

Part 3

Rectal Cancer: Staging, Neoadjuvant Therapy and TME

Rectal Cancer and Total Mesorectal Excision

TME removes the rectum and intact mesorectal envelope along the correct pelvic plane. This reduces local recurrence and is a fundamental component of mid/low rectal cancer surgery. Pathological assessment of the TME specimen provides quality information.

Circumferential Resection Margin

The CRM is the radial margin around a rectal tumour and mesorectum. MRI can identify a threatened margin before treatment; final pathology confirms whether the margin is clear. A threatened CRM often influences neoadjuvant strategy.

Neoadjuvant Therapy for Rectal Cancer

Locally advanced rectal cancers may receive chemotherapy, chemoradiation, short-course radiation or combinations before surgery. The purpose is to improve systemic/local control and facilitate complete resection. The best sequence depends on MRI risk features and patient factors.

Total Neoadjuvant Therapy - TNT

TNT delivers systemic chemotherapy and pelvic radiation before surgery rather than reserving some chemotherapy for afterward. It is increasingly used for selected locally advanced rectal cancers. Sequence and regimen should be individualized.

Response Assessment After Neoadjuvant Treatment

Restaging uses clinical examination, endoscopy and MRI, with CT as appropriate. Tumour regression can influence surgical planning, but residual microscopic disease may remain despite excellent imaging response. Timing of assessment matters.

Watch-and-Wait Strategy

Selected rectal cancer patients with a rigorous complete clinical response after neoadjuvant therapy may enter intensive non-operative surveillance at expert centres. This is not simply omission of surgery after tumour shrinkage. Local regrowth can occur and requires rapid salvage treatment.

Rectal Cancer Sequencing at a Glance

SituationUsual directionWhy it matters
Early tumour, clear margin on MRI, no concerning nodesSurgery first may be reasonableFinal pathology then guides adjuvant therapy
Threatened mesorectal fascia, involved nodes or locally advanced diseaseChemotherapy and/or radiation before surgery, sometimes as TNTShrinks disease and improves the chance of clear margins
Complete clinical response after treatmentSelected patients may enter watch-and-wait at expert centresNeeds intensive surveillance and a team experienced in the strategy
Very low tumour near the sphincterSphincter preservation versus APR must be assessed carefullySafe cancer clearance comes before stoma avoidance
Part 4

Rectal Operations, Stoma and Function

Low Anterior Resection

Low anterior resection removes the rectal tumour while preserving the anus and creating a colorectal or coloanal anastomosis. It is appropriate when adequate distal and circumferential clearance and acceptable function are achievable. A temporary diverting ileostomy is often considered for low connections.

Sphincter-Preserving Surgery for International Patients in India for Colorectal Cancer

Modern TME, neoadjuvant therapy and reconstructive techniques allow many low rectal cancers to be treated without permanent colostomy. Preservation is appropriate only when oncologic margins and functional sphincter are adequate. Avoiding a stoma should never compromise cure.

Abdominoperineal Resection

APR removes the rectum and anus and creates a permanent colostomy. It is required when the tumour involves the sphincter/levator complex or when a safe functional anastomosis is not possible. Specialized technique can reduce margin problems in selected low tumours.

Intersphincteric Resection

Selected very low rectal cancers can be removed with partial or complete internal sphincter resection and coloanal reconstruction. This may avoid permanent stoma but can cause significant bowel dysfunction. Careful functional counselling is essential.

Local Excision and TAMIS/TEMS

Selected small favourable early rectal cancers can be removed transanally without TME. Accurate staging and pathology are critical because adverse features can require completion radical surgery. Local excision is not adequate for most invasive rectal cancers.

Temporary Diverting Ileostomy

A loop ileostomy can protect a low pelvic anastomosis by diverting stool while healing occurs. It does not prevent every leak but can reduce the consequences of leakage. Reversal is a second operation and should be planned.

Permanent Colostomy

Permanent colostomy may be required after APR or when safe bowel continuity cannot be restored. With proper stoma siting and education, many patients resume active lives. Preoperative stoma-nurse marking improves appliance fit.

Anastomotic Leak

Leak from a bowel connection is one of the most important complications after colorectal surgery. Management ranges from antibiotics/drainage to reoperation and diversion. Risk is higher with low rectal anastomoses, poor nutrition and other factors.

Bowel Function After Rectal Surgery

Low anterior resection syndrome can include urgency, clustering, frequency and incontinence. Symptoms often improve but can persist, particularly after low anastomosis and pelvic radiation. Diet, medication, pelvic-floor therapy and irrigation can help selected patients.

Urinary and Sexual Function for International Patients in India for Colorectal Cancer

Pelvic autonomic nerves can be affected by tumour, radiation or surgery. High-quality TME aims to preserve these nerves when oncologically safe. Men and women should receive preoperative counselling about potential functional changes.

Operations and Stoma at a Glance

OperationWhat it involvesPoints to ask
Low anterior resectionRemoves the tumour and keeps the anusAsk about the chance of a temporary ileostomy and the leak rate
Intersphincteric resectionPart of the sphincter is removed for very low tumoursAsk about function and when it is oncologically safe
Abdominoperineal resectionRemoves the rectum and anus with a permanent colostomyAsk why sphincter preservation is not safe
Local excision / TAMIS
/ TEMSRemoves selected early tumours through the anusAsk whether your tumour is suitable and what pathology would trigger further surgery
Temporary diverting ileostomyProtects a low connection while it healsAsk when it will be reversed, and where
Part 5

Systemic Therapy and Biomarkers

Adjuvant Chemotherapy for Colon Cancer

Stage III colon cancer commonly receives postoperative chemotherapy, while selected high-risk stage II cancers may also benefit. MMR status and pathological risk features contribute to decisions. Regimen and duration depend on recurrence risk and tolerance.

Adjuvant Therapy for Rectal Cancer

The postoperative role of chemotherapy depends on the preoperative regimen, pathological findings and whether total neoadjuvant therapy was used. Treatment should not be copied directly from colon-cancer pathways. The entire sequence must be considered.

RAS and BRAF Testing

In metastatic colorectal cancer, RAS and BRAF status help select targeted therapy and provide biological information. BRAF V600E identifies a clinically important subgroup. Testing is most relevant when systemic treatment choices depend on it.

HER2 and Other Molecular Targets

HER2 amplification and other actionable alterations occur in selected colorectal cancers. Broader molecular testing may be useful in refractory metastatic disease when results could change treatment. Testing should be purposeful rather than indiscriminate.

Immunotherapy

Checkpoint inhibitors can produce durable responses in many MSI-high/dMMR metastatic colorectal cancers and are increasingly relevant in selected earlier-stage research/clinical contexts. Most microsatellite-stable cancers do not respond similarly. MMR/MSI testing is therefore essential.

Biomarkers and Treatment at a Glance

Test or therapyWhat it tells youPoints to ask
MMR/MSIMismatch-repair status; affects hereditary-risk evaluation and treatmentHas it been done on every colorectal cancer?
RAS and BRAFGuide targeted therapy options in advanced diseaseIs it needed at my stage?
HER2 and other targetsSelected molecular targets in advanced diseaseIs broader testing appropriate for me?
Adjuvant chemotherapyTreatment after surgery based on final pathologyIs it needed at my pathological stage, and who will give it?
ImmunotherapyUsed in selected settings, notably mismatch-repair deficient cancersAm I eligible, and can it be continued at home?
Part 6

Metastatic and Advanced Disease for International Patients in India for Colorectal Cancer

Liver Metastases

The liver is a common metastatic site. Selected patients with limited liver disease can undergo resection, ablation or combined strategies with systemic therapy and achieve long-term survival. Resectability should be reviewed by an experienced liver surgeon, not determined only by lesion number.

Lung Metastases

Selected isolated lung metastases can be treated with surgery, stereotactic radiation or ablation depending on number, location, disease control and fitness. Systemic disease biology remains important.

Synchronous Primary and Liver Metastases for International Patients in India for Colorectal Cancer

When colon/rectal cancer and liver metastases are diagnosed together, treatment can be bowel-first, liver-first or simultaneous in selected cases. The sequence depends on symptoms, rectal treatment needs and hepatic burden. Multidisciplinary planning avoids unnecessary delays.

Peritoneal Metastases and CRS-HIPEC

Selected patients with limited resectable peritoneal disease may be evaluated for cytoreductive surgery. The role of HIPEC varies by protocol and evidence, while complete cytoreduction is central. Extensive small-bowel disease or systemic progression can make surgery inappropriate.

Oligometastatic Colorectal Cancer

A limited number of metastases in liver, lung or other sites can sometimes be treated aggressively with surgery or local ablation alongside systemic therapy. The goal can remain long-term disease control or cure in selected patients. Patient selection depends on biology and technical resectability.

Locally Advanced Colon Cancer

Tumours invading adjacent organs may require en-bloc multivisceral resection rather than peeling the tumour away. This can include bladder, abdominal wall, small bowel or reproductive organs. The operation should be planned at a centre capable of multidisciplinary reconstruction.

Locally Recurrent Rectal Cancer

Pelvic recurrence after previous surgery/radiation can require complex exenterative surgery, sacral resection or re-irradiation strategies. Complete resection offers the best chance of durable control in selected patients. These cases should be centralized to high-expertise teams.

Pelvic Exenteration

For selected locally advanced or recurrent pelvic cancers, en-bloc removal of multiple pelvic organs may be required. This is major surgery with substantial functional consequences and reconstruction needs. International patients require extensive preoperative counselling and prolonged recovery planning.

Part 7

Emergencies, Nutrition and Enhanced Recovery

Emergency Presentation

Obstruction, perforation or major bleeding may require urgent surgery, stenting or diversion. Emergency treatment can differ from elective oncologic surgery and carries higher risk. Unstable patients should be treated locally rather than delaying for travel.

Colon Stenting

Self-expanding metal stents can relieve selected left-sided malignant obstructions as a bridge to surgery or palliation. They are not appropriate for every obstruction and require experienced endoscopy. Perforation risk must be considered.

Nutrition and Prehabilitation for International Patients in India for Colorectal Cancer

Weight loss, anaemia and low muscle mass increase complications. Protein/calorie support, exercise, smoking cessation and correction of deficiencies can improve readiness when time permits. Optimization should not create unsafe oncologic delay.

Enhanced Recovery After Surgery

ERAS pathways use multimodal pain control, early feeding and mobilization, avoidance of unnecessary tubes and structured discharge criteria. They can shorten recovery after open and minimally invasive surgery. Early discharge does not mean internal healing is complete.

Part 8

Surveillance and Long-Term Follow-Up

Surveillance After Curative Treatment

Follow-up typically combines clinical review, CEA, interval CT in appropriate stages and colonoscopy. Exact frequency depends on stage, guidelines and prior findings. Surveillance aims to detect treatable recurrence and new colorectal lesions.

Preparing Yourself Before Colorectal Surgery (Prehab)

Preparation helps recovery. Always agree what is appropriate with your surgical team, and never let preparation delay urgent cancer treatment:

  • Early dietitian review with a high-protein plan, and supplements if you are losing weight
  • Daily walking and general fitness as advised by your team
  • Breathing exercises before major abdominal surgery
  • Stopping smoking and limiting alcohol, which supports healing and lowers complications
  • Treating anaemia, a common problem with bowel bleeding, as advised
  • A medicine review, including blood thinners, diabetes medicines, supplements and herbal products
  • Stoma education and site marking before surgery, if a stoma is possible
  • Pelvic floor exercises and continence advice before rectal surgery
  • A fertility and sexual-health discussion before pelvic treatment, where relevant
  • Practical and emotional support arranged for you and your companion

Preparation should never delay urgent cancer treatment. Your team will tell you if time is critical.

Around Colorectal Cancer Treatment: What to Expect

StageWhat usually happens
Before treatmentColonoscopy, pathology and imaging review, MMR/MSI and molecular testing, tumour-board sequencing, stoma education and site marking, fitness and nutrition assessment, and consent covering the operation, stoma and complications
Before surgery (if indicated)Chemotherapy and/or pelvic radiation, with restaging to confirm response and plan the operation
Surgery and hospital stayColectomy or rectal resection, laparoscopic, robotic or open, with early walking, enhanced-recovery care and graded feeding
Early recovery in IndiaWound, stoma and drain checks, final pathology review, the adjuvant-treatment decision and fit-to-fly assessment
After you return homeGradual recovery of bowel function over weeks to months, chemotherapy where recommended, stoma reversal planning if relevant, and a written colonoscopy and imaging schedule
Part 9

Choosing Your Surgeon, Centre and City

Choosing a Colorectal Cancer Surgeon in India

Look for a colorectal/surgical oncologist with substantial experience in the exact operation, particularly TME, sphincter-preserving surgery, recurrent pelvic disease or combined metastatic surgery when relevant. Ask about anastomotic leak, stoma strategy and functional outcomes, not only robotic access.

Choosing a Comprehensive Colorectal Cancer Centre

A strong centre integrates GI pathology, endoscopy, high-quality rectal MRI, medical/radiation oncology, colorectal surgery, liver/thoracic surgery, interventional radiology, stoma therapy and ICU support. Tumour-board review is particularly valuable for rectal and metastatic disease.

Major Colorectal Cancer Treatment Hubs in India

Delhi NCR, Mumbai, Chennai, Bengaluru, Hyderabad and other tertiary centres provide advanced colorectal surgery, robotic/laparoscopic approaches, liver surgery and modern radiation/systemic therapy. The correct team should be selected by disease complexity rather than city alone.

Warning Signs of an Unreliable Offer for International Patients in India for Colorectal Cancer

Medical travel works best when the information you receive is specific, itemized and clinically sensible. Be cautious if you see any of the following:

Red Flags

  • A surgery date or price before the exact stage is known, or for rectal cancer before a dedicated pelvic MRI has been reviewed
  • No discussion of whether treatment should begin before surgery when your rectal MRI suggests it should be considered
  • Promises of a 'cure', 'guaranteed' results, or that you will 'definitely avoid a stoma'
  • Robotic surgery presented as the main reason to choose a hospital, with no discussion of cancer clearance
  • No MMR/MSI or molecular testing discussed, or no review of liver or lung metastases by a specialist
  • Omitting indicated radiation or chemotherapy to shorten your stay
  • No colorectal pathologist, medical oncologist, radiation oncologist, ICU or stoma nurse in the plan
  • Pressure to decide or pay quickly, or a base price with unclear exclusions for complications and reoperation
  • No plan for chemotherapy, stoma care and surveillance after you return home

What a Good International Patient Service Should Provide

A well-run programme should make the journey easier at every stage:

  • A named coordinator and a direct line to the clinical team before you travel
  • Review of your actual colonoscopy, pathology and imaging by the treating team, and a written preliminary opinion covering the stage, proposed sequence, operation and likelihood of a stoma
  • Honest discussion of alternatives, including treatment closer to home, and whether travel is necessary at all
  • An itemized written estimate that states what is included, how stoma, ICU, reoperation and complications are charged
  • A hospital letter for your medical visa application, and guidance for attendant visas
  • Airport pick-up, assistance on arrival and accommodation near the hospital for weeks
  • Interpreter support where needed
  • Final pathology with nodes and margins, operative report, discharge summary, stoma plan, systemic-therapy recommendation and surveillance schedule
  • A defined follow-up pathway after you return home, including teleconsultations with the treating team
Part 10

Cost, Packages and Quotations for International Patients in India for Colorectal Cancer

Indicative Colorectal Cancer Treatment and Surgery Costs in India

Treatment / ProcedureBroad International-Patient Planning Range
Laparoscopic / open colectomyApprox. US$5,000-8,000
Robotic colectomy / rectal resectionApprox. US$7,000-12,000
Low anterior resection / TMEApprox. US$6,000-11,000
APR with permanent colostomyApprox. US$6,000-11,000
Complex pelvic / multivisceral resectionApprox. US$10,000-20,000+
Colorectal liver metastasis surgeryApprox. US$8,000-20,000+ depending on extent
ChemotherapyApprox. US$500-3,000+ per cycle; regimen/drug dependent
Rectal chemoradiation / modern radiotherapyApprox. US$3,000-7,000+
CRS-HIPEC for selected peritoneal diseaseApprox. US$15,000-30,000+

These are broad private international-patient planning estimates, not guaranteed tariffs. Stoma creation, complex reconstruction, ICU care, liver surgery, imported targeted drugs, complications and prolonged admission can materially change cost.

What a Colorectal Surgery Package Should Include

Request the exact bowel/pelvic operation, laparoscopic/robotic/open approach, surgeon and anaesthesia fees, operating theatre, staplers/energy devices, planned ICU/ward stay, stoma creation and initial supplies, final pathology and routine postoperative review. Clarify whether interventional drainage, reoperation, stoma reversal and adjuvant treatment are separate.

Factors That Increase Total Treatment Cost

Very low rectal tumours, multivisceral resection, pelvic exenteration, liver/lung metastasis surgery, prolonged ICU care, anastomotic leak, abscess, stoma complications, targeted therapy and repeated systemic treatment can substantially increase the total pathway cost.

Colorectal Cancer Treatment Cost - India vs USA, UK and Australia

Representative TreatmentIndiaUSAUK PrivateAustralia PrivateApprox. India Saving*
Major colon / rectal resection$5k-12k$40k-120k+$20k-50k+$25k-60k+Approx. 40-96%
Complex pelvic /multivisceral surgery$10k-20k+$80k-200k+$40k-90k+$50k-100k+Approx. 50-95%
Rectal radiotherapy course$3k-7k$20k-50k+$10k-25k+$12k-30k+Approx. 30-94%
Selected chemotherapy cycle$0.5k-3k+$3k-15k+$1.5k-6k+$2k-7k+Approx. 0-97%

*Broad private/self-pay planning comparisons only. Targeted/immunotherapy drugs may show much narrower international price differences. Publicly funded pathways are not directly comparable with private international-patient packages.

Budgeting for the Whole Pathway, Not Just the Operation

The operation is only one part of the budget. Ask for the treatment quotation, then add:

  • Pelvic radiotherapy, chemotherapy, targeted or immunotherapy drugs and molecular tests that are not in the surgical package
  • A contingency for complications such as anastomotic leak, abscess, stoma problems or reoperation, which can materially raise the final bill
  • Stoma reversal, if planned, and where it will be done
  • Return flights for you and your companion, with flexibility to change dates if recovery is slow
  • Accommodation near the hospital for the whole stay, commonly about 2-5 weeks and longer after complex rectal or metastatic surgery
  • Meals, local transport and airport transfers
  • Visa fees, travel insurance and any attendant visa costs
  • Stoma supplies, nutrition support and home nursing, if needed
  • Follow-up colonoscopy, imaging and tests at home

Colorectal Cancer Treatment Quotation Comparison Table

ItemCentre ACentre B
Diagnosis / tumour location
Clinical stage
MMR/MSI / molecular tests
Neoadjuvant treatment
Planned operation
Laparoscopic / robotic / open
Sphincter preservation
Temporary / permanent stoma
ICU / ward nights
Pathology
Chemotherapy / radiation
Complication exclusions
Expected India stay
Total pathway estimate
Part 11

Your Journey: Records, Travel, Visa and Going Home for International Patients in India for Colorectal Cancer

Remote Case Review Before Travel

Send colonoscopy and biopsy, pathology, CT chest/abdomen/pelvis, pelvic MRI for rectal cancer, CEA, MMR/MSI results and any RAS/BRAF/molecular reports. Include prior chemotherapy/radiation and operative notes. Imaging should be shared in DICOM format whenever possible.

Records Checklist

  • Colonoscopy report and images; biopsy and pathology
  • CT chest/abdomen/pelvis images, not only reports
  • Pelvic MRI for rectal cancer, ideally DICOM
  • CEA, MMR/MSI and RAS/BRAF or other molecular reports
  • Prior chemotherapy and radiation doses and dates
  • Operative notes from any previous surgery
  • Medicine list, allergies and other conditions
  • Passport copy

Questions the Pre-Travel Opinion Should Answer

Is this colon or rectal cancer and what is the exact stage? Should treatment begin with surgery, chemotherapy or chemoradiation/TNT? Is sphincter preservation realistic? What is the probability of temporary/permanent stoma? Are liver/lung/peritoneal metastases potentially curable with local treatment? These decisions determine the correct sequence and realistic cost.

International Patient Treatment Journey

1) Remote pathology/imaging review. 2) multidisciplinary staging. 3) neoadjuvant treatment first if indicated. 4) travel/restaging. 5) bowel/rectal surgery. 6) pathology and recovery. 7) stoma education/reversal plan. 8) adjuvant treatment decision. 9) fit-to-fly. 10) surveillance at home. Rectal cancer patients should not book surgery before MRI-based treatment sequencing is clear.

How Long to Stay in India

Many uncomplicated colectomy patients can plan about 2-3 weeks in India; low rectal, stoma, metastatic or complex pelvic surgery often warrants 3-5 weeks or longer. Complications can extend this substantially. A flexible return ticket is advisable.

Flying After Colorectal Surgery

Long-haul travel should wait until bowel function, hydration, mobility, wounds and stoma management are stable. Cancer surgery increases thrombosis risk, so walking, hydration and individualized prophylaxis are important. Persistent ileus, infection or dehydration makes flying unsafe.

Travelling With a Stoma for International Patients in India for Colorectal Cancer

Patients should carry extra appliances in hand luggage, know how to manage leakage and dehydration, and obtain a written product list. Ileostomy patients are particularly vulnerable to high-output fluid and electrolyte loss. A stoma nurse should review technique before departure.

Airline and Travel Practicalities After Colorectal Surgery

Airline rules differ, so confirm each point with your airline before you fly:

TopicWhat to arrange
Fit-to-fly letterAsk your surgeon for written clearance stating the diagnosis, operation and date, and carry it in hand luggage; some airlines require a medical form after major abdominal surgery
Blood clotsCancer and major surgery raise clot risk; ask whether stockings or blood-thinning injections are needed, and walk and hydrate regularly in flight
Stoma suppliesPack plenty of spare bags, appliance details and skin care in hand luggage, and allow for gas expansion in the cabin
Hydration and ileostomy outputCarry oral rehydration advice, drink regularly, and know the output level at which to seek help
Drains and woundsConfirm that drains have been removed or are safe for travel; carry dressings and wound-care instructions
Eating and drinkingCarry suitable food, supplements and fluids as advised by your dietitian
Medicines and injectionsKeep all medicines, injections and painkillers in hand luggage with a prescription list and a letter for needles or syringes if needed
Seat choice and assistanceAn aisle seat near a toilet helps; request airport assistance if you tire easily
RecordsCarry final pathology, operative report, discharge summary and contact details of the treating team in case of a problem on the journey
Flexible tickets and insuranceBook a flexible return so that a delay in healing does not mean losing money, and check what travel insurance covers for surgery-related complications

Accommodation and Companion

A companion is strongly advised during surgery and recovery, for help with mobility, stoma and wound care, medicines, nutrition and decisions, and during chemotherapy or radiation if these start in India. Accommodation should be close to the hospital with easy toilet access, so that fever, pain or high stoma output can be reviewed promptly.

Medical Visa and Travel Planning

Confirm current Indian medical-visa requirements through official channels, including the attendant visa for your companion. Carry the hospital invitation, a medical summary, your pathology and imaging and your medicines, and keep the visa duration and return travel flexible in case recovery or radiation takes longer than planned.

Continuing Chemotherapy at Home

Carry the final pathology, TNM stage, MMR/MSI and molecular results, exact recommended regimen, dose schedule and supportive medication plan. Confirm drug availability with the home oncology team. For rectal cancer, document all neoadjuvant chemotherapy/radiation doses.

Post-Return Follow-Up

Provide the home team with operative report, pathology including nodes/margins, stoma plan, chemotherapy/radiation summary and surveillance schedule. Arrange colonoscopy and imaging according to stage. Patients with liver/lung metastases need coordinated multidisciplinary surveillance.

Arranging Your Follow-Up Care at Home Before You Leave

Treatment and surveillance continue for years, so set up your home team before you travel and confirm it again before you fly home:

WhoRole
Local medical oncologistGives adjuvant or ongoing systemic therapy and monitors blood tests and side effects
Radiation oncologistReviews any pelvic radiation given and delivers further radiation if recommended
Colorectal surgeon or emergency departmentKnows your history and can assess a leak, abscess, obstruction or stoma problem quickly, using your operative report
Stoma nurseSupports appliance fitting, skin care, supplies and reversal planning
Endoscopy and imaging serviceCarries out colonoscopy, CT, MRI and CEA tests on the agreed schedule, comparing with earlier images
Dietitian and pelvic-floor physiotherapistSupport nutrition, bowel function, continence and recovery of stamina
Genetic counsellorAdvises on Lynch syndrome, polyposis and family testing where indicated
General practitionerCoordinates care, general health, medicines and referrals
Overseas treating teamTeleconsultations, review of scans and records, and advice on the plan

Hand-over Checklist

  • Written fit-to-fly clearance
  • Final pathology, including nodes and margins, and TNM stage
  • Operative report and discharge summary
  • MMR/MSI and molecular reports
  • Stoma plan, appliance specification and reversal plan
  • Neoadjuvant and adjuvant treatment summaries, with radiation doses
  • Medicine list and supportive medication plan
  • Nutrition, hydration and activity instructions
  • Colonoscopy and imaging schedule with next appointments
  • Home oncologist details and emergency plan

Warning Signs

Urgent assessment is required for fever, worsening abdominal pain, persistent vomiting, abdominal distension, inability to pass stool/gas, heavy rectal/stoma bleeding, wound drainage, breathlessness, leg swelling or very high ileostomy output with dehydration. Anastomotic leak, obstruction, abscess and thromboembolism require prompt local evaluation.

Do Not Wait for an Overseas Reply

Fever, worsening abdominal pain, persistent vomiting, a swollen abdomen with no stool or gas, heavy bleeding, a wound that opens or discharges, breathlessness, a swollen painful leg or very high stoma output with dehydration needs emergency care where you are. Tell the emergency team about your diagnosis and surgery, show your operative report, and contact your treating team afterwards.

Part 12

Tools: Questions, Candidacy, FAQ and Checklist for International Patients in India for Colorectal Cancer

Twenty Questions to Ask the Colorectal Cancer Team

  1. 1Is my tumour in the colon or rectum?
  2. 2What is my exact TNM stage?
  3. 3Has MMR/MSI testing been performed?
  4. 4Do I need RAS/BRAF or broader molecular testing?
  5. 5For rectal cancer, has a dedicated pelvic MRI been reviewed?
  6. 6Should I receive treatment before surgery?
  7. 7If rectal cancer, am I a candidate for total neoadjuvant therapy?
  8. 8What exact operation do you recommend?
  9. 9Can the operation be laparoscopic or robotic without compromising cancer clearance?
  10. 10How many lymph nodes are expected to be assessed?
  11. 11For rectal cancer, what is my circumferential margin risk?
  12. 12Can my anal sphincter be preserved safely?
  13. 13What is the chance of a temporary stoma?
  14. 14What is the chance of a permanent stoma?
  15. 15What is your anastomotic leak rate for this operation?
  16. 16Are any liver/lung metastases potentially resectable or ablatable?
  17. 17Will I need chemotherapy or radiation afterward?
  18. 18What exactly is included in the quotation?
  19. 19How long should I remain in India?
  20. 20What surveillance and colonoscopy schedule will I need at home?

Who Is a Good Candidate for Colorectal Cancer Medical Travel?

A suitable patient is medically stable and has enough pathology/imaging to establish a coherent treatment sequence. Travel can be particularly valuable when the patient needs expert sphincter-preserving rectal surgery, complex minimally invasive surgery, combined liver/colorectal treatment or a multidisciplinary second opinion.

When Travel Should Not Delay Urgent Care for International Patients in India for Colorectal Cancer

Complete bowel obstruction, perforation, peritonitis, uncontrolled bleeding, sepsis or severe dehydration require urgent local stabilization. International travel should not delay emergency decompression, diversion or surgery when clinically necessary.

Frequently Asked Questions for International Patients in India about Colorectal Cancer

1. Are colon and rectal cancer treated the same way?

No. Rectal cancer often needs pelvic MRI and preoperative chemotherapy/radiation planning.

2. Is colonoscopy enough for staging?

No. Biopsy confirms diagnosis, but CT and other stage-specific imaging are required.

3. What is MSI/MMR testing?

Testing for mismatch-repair deficiency/microsatellite instability; it affects hereditary-risk evaluation and treatment.

4. Does every colon cancer need chemotherapy?

No. It depends mainly on pathological stage, risk features and patient factors.

5. Why is MRI important in rectal cancer?

It defines pelvic tumour extent, nodes, sphincter relationship and circumferential margin risk.

6. What is TME?

Total mesorectal excision, the standard oncologic surgical plane for many rectal cancers.

7. Can rectal cancer surgery avoid a permanent colostomy?

Often yes, but only when adequate margins and acceptable sphincter function can be preserved.

8. Is a temporary ileostomy always needed?

No, but it is commonly used to protect selected low rectal anastomoses.

9. Can colorectal cancer surgery be robotic?

Yes in selected cases; laparoscopic and open approaches can also provide excellent oncologic results.

10. What is total neoadjuvant therapy?

Delivery of chemotherapy and pelvic radiation before rectal surgery in selected locally advanced disease.

11. Can surgery sometimes be avoided after rectal cancer treatment?

Selected complete clinical responders can enter intensive watch-and-wait programmes at expert centres.

12. Can liver metastases be cured?

Selected resectable liver metastases can be treated with curative intent using surgery/ablation and systemic therapy.

13. What does colorectal cancer surgery cost in India?

Many major resections broadly fall around US$5,000-12,000; complex surgery costs more.

14. How much can India save?

Broad private comparisons often show substantial savings, commonly about 40-90% or more depending on treatment.

15. How long should I stay in India?

Often 2-4 weeks after uncomplicated surgery; complex rectal/metastatic cases may require longer.

16. Can I travel with a stoma?

Yes, once stable and trained, with adequate supplies and attention to hydration.

17. Do I need molecular testing?

MMR/MSI is broadly important; RAS/BRAF and other testing are especially relevant in metastatic disease.

18. Is HIPEC used for colorectal cancer?

Only in selected peritoneal-metastasis cases; complete cytoreduction and patient selection are central.

19. What records should I send before travel?

Colonoscopy, biopsy/pathology, CT, rectal MRI if relevant, CEA and molecular/treatment records.

20. What is the most important decision before booking surgery?

Establish whether surgery should occur first or after neoadjuvant treatment and whether metastatic disease changes the plan.

21. Can I travel on my own for colorectal cancer treatment?

It is strongly advisable to bring a companion. Stoma care, wound care, fatigue, hydration and decisions about further treatment are easier with support, and a companion can help if chemotherapy or radiation starts in India.

22. What if my surgeon wants to operate first but my rectal MRI suggests treatment first?

Ask for the reasoning in writing and for review by a multidisciplinary tumour board. A second opinion is reasonable, and the sequence should be settled before any operation is booked.

23. Is a lower price a reason to choose a centre?

No. Compare the clinical plan, the surgeon's colorectal and rectal cancer experience, the backup and the contingency for complications first. A low surgery price that excludes radiation, drugs and complications can end up costing more.

24. Can my home oncologist follow me after surgery?

Often yes, but only if they have agreed in advance and received the final pathology, stage, molecular reports, operative report and treatment recommendations. Confirm this before you leave India.

Colorectal Cancer Checklist for International Patients in India

Diagnosis / staging

  • Colonoscopy
  • Biopsy
  • CT chest/abdomen/pelvis
  • Rectal MRI if applicable
  • CEA
  • MMR/MSI
  • RAS/BRAF if indicated
  • Metastatic resectability review

Treatment decision

  • Surgery-first vs neoadjuvant
  • TNT if appropriate
  • Operation type
  • TME/CRM plan
  • Sphincter preservation
  • Stoma probability
  • Liver/lung strategy

Centre

  • Colorectal surgeon
  • GI pathology
  • Medical oncology
  • Radiation oncology
  • Liver/thoracic surgery
  • Interventional radiology
  • Stoma nurse
  • ICU

Cost

  • Surgery
  • Robotic consumables if used
  • Staplers
  • Stoma/supplies
  • ICU/ward
  • Pathology
  • Chemotherapy
  • Radiation
  • Complication exclusions

Travel

  • Medical visa
  • Attendant
  • Flexible return
  • Accommodation
  • DVT precautions
  • Stoma supplies
  • Hydration plan
  • Nutrition

Before return

  • Final pathology
  • Operative report
  • TNM stage
  • MMR/MSI/molecular reports
  • Stoma plan
  • Medication
  • Adjuvant plan
  • Fit-to-fly
  • Surveillance schedule
  • Home oncologist

Final Perspective

Colorectal cancer treatment has become increasingly multidisciplinary. For colon cancer, high-quality oncologic resection and stage-directed systemic therapy remain central. For rectal cancer, MRI-based risk assessment, neoadjuvant treatment, meticulous TME and thoughtful sphincter/stoma planning can profoundly influence both cancer control and long-term quality of life.

India offers experienced colorectal oncology teams, advanced laparoscopic and robotic surgery, modern pelvic radiotherapy, systemic therapy and combined liver/peritoneal treatment at major tertiary centres. International patients should compare complete treatment strategies rather than selecting a hospital on the basis of a low surgery price or a promise of robotic surgery alone.

Send your colonoscopy and biopsy reports, pathology, CT chest/abdomen/pelvis, pelvic MRI for rectal cancer, CEA, MMR/MSI and any RAS/BRAF or molecular reports, plus prior chemotherapy, radiation and operative notes, with imaging in DICOM format where possible. You will receive a preliminary opinion covering whether the cancer is colon or rectal and its stage, whether treatment should begin with surgery or neoadjuvant therapy, the likelihood of sphincter preservation and a stoma, the stay in India, an itemized cost estimate and a follow-up plan, so you can decide with a clear picture in hand.

Sources

  1. 1. American Cancer Society - Treatment of Colon Cancer, by Stage: https://www.cancer.org/cancer/types/colon-rectal-cancer/treating/by-stage-colon.html
  2. 2. American Cancer Society - Rectal Cancer Surgery: https://www.cancer.org/cancer/types/colon-rectal-cancer/treating/rectal-surgery.html
  3. 3. Government of India - Indian Visa Online (e-Medical Visa and e-Medical Attendant Visa): https://indianvisaonline.gov.in/evisa/

Important Medical Note. This guide provides general educational information and does not replace individualized assessment by a qualified colorectal cancer multidisciplinary team. Treatment sequence, surgery type, stoma need, chemotherapy/radiotherapy, metastatic treatment, cost and travel timing must be determined from the patient's pathology, tumour location, stage, MRI/CT findings, molecular profile, medical fitness and treatment goals.

Tags: Colorectal Cancer Treatment for International Patients in India, Colorectal Cancer Treatment in India, Colorectal Cancer Treatment Cost in India, Best Colorectal Cancer Hospital in India, Colorectal Cancer Specialist in India, Medical Visa for Colorectal Cancer Treatment in India, Colorectal Cancer Treatment Abroad, Colorectal Cancer Surgery in India, Colon Cancer Surgery in India, Rectal Cancer Surgery in India, Robotic Colorectal Surgery in India, Laparoscopic Colectomy in India, Total Mesorectal Excision in India, Stoma Care in India, Colorectal Liver Metastases Surgery in India, Lynch Syndrome Testing in India, Chemotherapy for Colon Cancer in India, Colonoscopy in India

Quote